MARAGANORE JOHN 4
4 · AGIOS PHARMACEUTICALS, INC. · Filed May 24, 2022
Insider Transaction Report
Form 4
MARAGANORE JOHN
Director
Transactions
- Exercise/Conversion
Common stock
2022-05-20+1,585→ 30,028 total - Exercise/Conversion
Restricted stock unit
2022-05-20−1,585→ 0 total→ Common stock (1,585 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
- [F2]The restricted stock units were granted on May 20, 2021. The shares underlying the stock units will vest in full on May 20, 2022. Vested shares will be delivered to the reporting person within three business days after such shares become vested